Cargando…
Co-administration of lipopolysaccharide and d-galactosamine induces genotoxicity in mouse liver
The acute liver injury (ALI) and hepatic fibrosis caused by the co-treatment of lipopolysaccharide (LPS)/d-galactosamine (D-GalN) have been extensively studied. However, whether LPS/D-GalN are genotoxic has been left unknown. In this study, male mice were divided into eight groups with eight animals...
Autores principales: | Dong, Wenjing, Song, Erqun, Song, Yang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7814041/ https://www.ncbi.nlm.nih.gov/pubmed/33462304 http://dx.doi.org/10.1038/s41598-021-81383-5 |
Ejemplares similares
-
Intraperitoneal Administration of Fetuin-A Attenuates d-Galactosamine/Lipopolysaccharide-Induced Liver Failure in Mouse
por: Zhang, Pan, et al.
Publicado: (2014) -
Guanabenz Prevents d-Galactosamine/Lipopolysaccharide-Induced Liver Damage and Mortality
por: Perego, Jessica, et al.
Publicado: (2017) -
The Protective Effect of Cordycepin on D-Galactosamine/Lipopolysaccharide-Induced Acute Liver Injury
por: Li, Jin, et al.
Publicado: (2017) -
Carfilzomib Mitigates Lipopolysaccharide/D-Galactosamine/Dimethylsulfoxide-Induced Acute Liver Failure in Mice
por: Alhareth, Dhafer Y., et al.
Publicado: (2023) -
Deficiency of interleukin-19 exacerbates
lipopolysaccharide/D-galactosamine-induced acute liver failure
por: FUJIMOTO, Yasuyuki, et al.
Publicado: (2020)